Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avax Technologies Inc.

www.avax-tech.com

Latest From Avax Technologies Inc.

Reaping in due season? R&D trends and novel drug launches

In the fashion world, hemlines drop at the first hint of a recession, but seasons in pharmaceutical R&D are more reminiscent of those in the A Game of Thrones’ mythical land of Westeros – they change very slowly.

Cardiovascular Cancer

With Shire Behind Him, Jonas Starts New Chapter At SAGE

The upbeat ex-Shire exec has moved on from his tumultuous break-up with the specialty pharma and is on day three in his new role as CEO of CNS start-up SAGE Therapeutics. He will focus on bringing CNS products forward for orphan indications.

BioPharmaceutical North America

INTERVIEW: Acquired assets key to Shire's 'entrepreneurial' approach to regen medicine

The evolution of Shire's entrepreneurial regenerative medicine business continues with the appointment of Jeff Jonas as president of the division, which has been headquartered in San Diego, US since the $750 million acquisition of Advanced BioHealing and its bio-engineered skin substitute for diabetic foot ulcers Dermagraft in 2011 (scripintelligence.com, 18 May 2011).

Dermatology

Newly Appointed Head of Regenerative Medicine At Shire Plans Rapid Growth For The Division

Jeff Jonas takes over Shire’s newly formed Regenerative Medicine business with plans for rapid growth, replacing Advanced BioHealing’s Kevin Rakin in the role.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Avax Technologies Inc.
  • Senior Management
  • Richard P Rainey, CFO
    David Berd, CMO
  • Contact Info
  • Avax Technologies Inc.
    Phone: (215) 241-9760
    2000 Hamilton Street
    Ste. 204
    Philadelphia, PA 19130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register